Regeneron Pharmaceuticals Aktie
673,54USD | -0,12USD | -0,02% |
WKN: 881535 / ISIN: US75886F1075
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 9 123 | 10 368 | 11 851 | 13 450 | 15 106 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,93 | 1,55 | 1,03 | 0,98 | 0,94 |
Bilanz (in Mio. USD) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 9 779 | 14 015 | 15 884 | 19 479 | 18 661 |
Summe Anlagevermögen | 7 384 | 11 420 | 13 389 | 13 651 | 19 192 |
Summe Aktiva | 17 163 | 25 435 | 29 273 | 33 131 | 37 852 |
Bilanz (in Mio. USD) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 6 138 | 6 666 | 6 609 | 7 158 | 8 499 |
Summe Eigenkapital | 11 025 | 18 769 | 22 664 | 25 973 | 29 354 |
Summe Passiva | 17 163 | 25 435 | 29 273 | 33 131 | 37 852 |
Adresse
777 Old Saw Mill River Road, 10591-6707 Tarrytown | |
Telefon | +1 (914) 847-7000 |
Internet | http://www.regeneron.com |
Management
Alan Shuldiner
Vice President-Translational Genetics |
Andrew J. Murphy
Executive Vice President-Research |
Arthur Frederick Ryan
Independent Director |
Benjamin Drosman
SVP-Regulatory Compliance & Global Development |
Boaz Hirshberg
SVP-Clinical Sciences General Medicine |
Bob McCowan
Chief Information Officer & Senior VP-IT |
Bola Akinlade
Senior Vice President-Clinical Development |
Bonnie L. Bassler
Independent Director |
Christine A. Poon
Lead Independent Director |
Christine Childrose
Senior Vice President-Human Resources & Operations |
Christopher Robert Fenimore
Chief Financial Officer & Senior VP-Finance |
Christos Kyratsous
Senior Vice President-Research |
Craig B. Thompson
Independent Director |
Daniel P. van Plew
EVP, GM-Industrial Operations & Product Supply |
David Paul Schenkein
Director |
David Simon
Senior Vice President-Business Operations |
George Damis Yancopoulos
Co-Chairman & Co-President |
George L. Sing
Independent Director |
Gerald Underwood
Senior Vice President-Technical Operations |
Huda Y. Zoghbi
Independent Director |
Jason Pitofsky
Vice President & Controller |
John Calabro
Senior Vice President-Internal Auditor |
Johnathan M. Lancaster
Senior Vice President-Global Medical Affairs |
Joseph J. LaRosa
Secretary, Executive VP & General Counsel |
Joseph L. Goldstein
Independent Director |
Kathryn W. Guarini
Independent Director |
Kerry K. Reinertsen
Senior Vice President-Strategic Alliances |
Leonard Brooks
Treasurer & Senior Vice President |
Leonard S. Schleifer
Co-Chairman, Co-President & CEO |
Lori Morton
Senior Vice President-Research |
Lynn Macdonald
Senior Vice President-Research |
Marion McCourt
Executive Vice President-Commercial |
Mark Hudson
Head-Investor Relations |
Mark Volpe
Senior Vice President-Tax |
Maya Bermingham
Senior VP-Public Policy & Government Affairs |
Melissa Lozner
Chief Compliance Officer & Senior Vice President |
Michael S. Brown
Independent Director |
N. Anthony Coles
Independent Director |
Ned Braunstein
SVP-Regulatory Affairs & Global Patient Safety |
Neil Stahl
Executive VP-Research & Development |
Nouhad Husseini
Senior VP-Business Development |
Patrice Gilooly
Senior VP-Quality Assurance & Operations |
Ryan Crowe
Head-Investor Relations |
Sally A. Paull
Executive Vice President-Human Resources |
Smita Pillai
Chief Diversity, Equity & Inclusion Officer |